Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priti Kumar

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2009
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT miceSang-Soo Kim, Dan Peer, Priti Kumar, et al.
Molecular Pharmaceutics|May 5, 2020
Targeted Delivery of Recombinant Heat Shock Protein 27 to Cardiomyocytes Promotes Recovery from Myocardial InfarctionNahyeon Kim, Irfan Ullah, Kunho Chung, et al.
Plos Pathogens|December 6, 2019
Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized miceJohn D Ventura, Jagadish Beloor, Edward Allen, et al.
Biomaterials|November 25, 2011
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNAJagadish Beloor, Chang Seon Choi, Hye Yeong Nam, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapyHendrik Jahnz, Martin V Hamann, Hongil Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2018
Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infectionShalley N Kudalkar, Jagadish Beloor, Elias Quijano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2017
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infectionShalley N Kudalkar, Jagadish Beloor, Elias Quijano, et al.
Journal of Virology|December 18, 2009
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine productionSandesh Subramanya, Sang-Soo Kim, Sojan Abraham, et al.
Molecular Therapy. Nucleic Acids|November 21, 2013
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized MiceErica B Schleifman, Nicole Ali McNeer, Andrew Jackson, et al.
Blood|April 16, 2005
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIVSang-Kyung Lee, Derek M Dykxhoorn, Priti Kumar, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2009
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT miceSang-Soo Kim, Dan Peer, Priti Kumar, et al.
Molecular Pharmaceutics|May 5, 2020
Targeted Delivery of Recombinant Heat Shock Protein 27 to Cardiomyocytes Promotes Recovery from Myocardial InfarctionNahyeon Kim, Irfan Ullah, Kunho Chung, et al.
Plos Pathogens|December 6, 2019
Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized miceJohn D Ventura, Jagadish Beloor, Edward Allen, et al.
Biomaterials|November 25, 2011
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNAJagadish Beloor, Chang Seon Choi, Hye Yeong Nam, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapyHendrik Jahnz, Martin V Hamann, Hongil Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2018
Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infectionShalley N Kudalkar, Jagadish Beloor, Elias Quijano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2017
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infectionShalley N Kudalkar, Jagadish Beloor, Elias Quijano, et al.
Journal of Virology|December 18, 2009
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine productionSandesh Subramanya, Sang-Soo Kim, Sojan Abraham, et al.
Molecular Therapy. Nucleic Acids|November 21, 2013
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized MiceErica B Schleifman, Nicole Ali McNeer, Andrew Jackson, et al.
Blood|April 16, 2005
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIVSang-Kyung Lee, Derek M Dykxhoorn, Priti Kumar, et al.
Pageof 13